Vivonics subsidiary, CranioSense wins the Johnson & Johnson Innovation Award at the 2020 M2D2 $200K Challenge!

“The Massachusetts Medical Device Development Center (M2D2) is a lifeline for the state’s smaller medical device companies, offering inventors and executives easy, affordable, and coordinated access to world-class researchers and resources at the UMASS Lowell and the UMass Medical School campuses of the University of Massachusetts.” More information about M2D2 can be found here!

When Gordon Hirschman was asked about the event, he responded with “we are honored to have received the award and particularly excited about the prospect of interacting with people from Johnson and Johnson, the world’s largest healthcare company.  Their broad and deep capabilities offer us a valuable opportunity for mentoring and networking.   Thank you to M2D2, all the sponsors, and especially JnJ!”

(IPASS)- Intracranial Pressure and Assessment Screening System

 IPASS is a noninvasive device for continuous assessment of intracranial pressure (ICP). ICP increases after a traumatic brain injury (TBI) due to a blow to the head or as a result of other medical conditions that impact the brain. In current practice, ICP is only continuously monitored by invasive devices requiring surgical installation. Vivonics is currently developing IPASS (Intracranial Pressure Assessment and Screening System) to provide a low-cost solution to quickly and easily assess ICP and continue to monitor for changes, allowing the physician to determine appropriate patient care.

 
Image for Johnson & Johnson innovation Award winner with the M2D2 logo.